While our data do not demonstrate a cause-and-effect relationship between the disruption in PUFA biology mediated by FADS1 inhibition and STING activation in AML, several previously reported correlative observations suggest that this may be a possibility. Here, FADS1 is linked to acute myeloid leukemia.